MEDomics Reports 44-fold Increase in Clinical Testing Sales at the OneMedPlace Investment Forum associated with the JP Morgan Healthcare Conference

Share Article

Next Generation Sequence-based Mitochondrial Medicine Molecular Diagnostic Testing

MEDomics provides NextGen sequence-based DNA diagnostic testing to enable personalized medicine in the genomics era and is transforming diagnostic testing for mitochondrial diseases. MEDomics was selected for an oral presentation at OneMedForum 2011 (http://www.onemedplace.com). In the context of the huge turn out that the annual J.P. Morgan Health Care Conference receives, OneMedPlace has become the venue for small cap and young health care companies to present to investors, angels, venture capitalists and investment banks.

Entering its third year of operations, MEDomics is seeing exceptional growth in its clinical revenue through acceptance of its mitochondrial disease tests. The firm saw an over 40-fold increase in clinical revenue since the summer, exceeded projections for 2010 and expects a strong and profitable 2011.

According to Dr. Steve Sommer, Founder and President, “The mitochondrial disease tests based on Next Generation sequencing improve the utilization of blood tests to evaluate patients suspected to have mitochondrial diseases. For the physician, use of the more sensitive and comprehensive molecular tests can : i) dramatically simplify testing, ii) enhance the fraction of genetic diagnoses, iii)often remove the need for painful and expensive surgical muscle sampling, iv) enable rational therapy, and v) provide prognostic information for enhanced familial risk counseling.”

MEDomics, LLC (http://www.medomics.com) is a molecular diagnostic laboratory founded in 2008 by Steve S. Sommer, MD, PhD, with the mission of providing Mutation Expert-based Diagnosis ("MED") to support the physician in delivering personalized medicine based on analysis of the patient's genome ("omics"). MEDomics is a CLIA Certified Laboratory and a leader in the clinical diagnostic application of Next Generation sequencing. The mutation experts at MEDomics provide unparalleled quality interpretation to aid the practicing physician. The staff at MEDomics “live and breathe” mitochondrial medicine.

Contact Information:
MEDomics, LLC
426 N. San Gabriel Ave.
Azusa, CA 91702 (near Pasadena)
http://www.medomics.com
Phone: (626) 804-3645

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

MEDomics LLC

(626) 804-3645
Email >
Visit website